|
HDGF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.816200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.504400E-01 |
| Normal-vs-Stage2 |
5.719800E-01 |
| Normal-vs-Stage3 |
1.014030E-01 |
| Normal-vs-Stage4 |
7.301900E-02 |
| Stage1-vs-Stage2 |
5.388000E-01 |
| Stage1-vs-Stage3 |
5.265800E-02 |
| Stage1-vs-Stage4 |
2.536000E-02 |
| Stage2-vs-Stage3 |
4.239000E-01 |
| Stage2-vs-Stage4 |
1.698450E-01 |
| Stage3-vs-Stage4 |
4.966600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.436200E-02 |
| Normal-vs-AfricanAmerican |
7.706400E-01 |
| Normal-vs-Asian |
4.235600E-01 |
| Caucasian-vs-AfricanAmerican |
2.828000E-01 |
| Caucasian-vs-Asian |
2.278400E-01 |
| AfricanAmerican-vs-Asian |
3.404600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.315200E-01 |
| Normal-vs-Female |
1.034230E-02 |
| Male-vs-Female |
3.013600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.299600E-01 |
| Normal-vs-Extreme_Weight |
5.989400E-01 |
| Normal-vs-Obese |
8.644100E-03 |
| Normal-vs-Extreme_Obese |
5.003800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.448990E-01 |
| Normal_Weight-vs-Obese |
2.253200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.344600E-01 |
| Extreme_Weight-vs-Obese |
5.835100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.898800E-01 |
| Obese-vs-Extreme_Obese |
1.046410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.314000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.520430E-01 |
| Normal-vs-Age(61-80Yrs) |
4.420000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.959800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.222800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.259100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.037600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.819800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.636560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.115800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.154170E-01 |
| Normal-VS-Type2 PRCC |
7.890000E-01 |
| Normal-VS-KIRP CIMP |
1.296390E-02 |
| Normal-VS-Unclassified PRCC |
4.528000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.607980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.604500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.587600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.194820E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.760200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.382500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.118200E-01 |
| Normal-vs-N1 |
1.057820E-02 |
| Normal-vs-N2 |
6.42319999999419E-05 |
| N0-vs-N1 |
9.303600E-03 |
| N0-vs-N2 |
5.231900E-02 |
| N1-vs-N2 |
8.567800E-01 |
|
|
